• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Conatus Pharmaceuticals Inc. (CNAT)

    -NasdaqGM
    6.66 Down 0.15(2.20%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.81
    Open:6.93
    Bid:6.60 x 500
    Ask:6.97 x 300
    1y Target Est:13.67
    Beta:-0.520
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:6.60 - 6.93
    52wk Range:5.06 - 11.74
    Volume:512,402
    Avg Vol (3m):679,422
    Market Cap:127.85M
    P/E (ttm):N/A
    EPS (ttm):-1.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CNAT

    Comparison

    Symbol% ChgMkt Cap
    CNATDown 2.20%127.85M
    GALTDown 1.20%77.74M
    ICPTDown 0.78%6.77B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.53
    Quarterly EPS Est (Mar-15) :-0.37
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-4.35

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback